Similar 3-year metastasis-free survival, fewer hot flashes, more gynecomastia ...

Hormone patches are as good at controlling locally advanced prostate cancer as the injections typically used to deliver ...

When prostate cancer spreads beyond the prostate gland to other parts of the body, it becomes what medical professionals call metastatic prostate cancer. This advanced form of the disease represents a ...

Pfizer is eyeing an earlier use of its PARP inhibitor Talzenna after a positive phase 3 trial in metastatic hormone-sensitive ...

(NYSE: PFE) today announced positive topline results from the Phase 3 TALAPRO-3 study of TALZENNA ® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI ® ...

A new experimental drug is showing potential in treating prostate cancer and possibly other forms of the disease.

Clinical and pathologic characteristics of mCRPC were largely similar between younger and older patients. Overall survival was not significantly different between younger and older patients with mCRPC ...

Bridging gaps: Evaluating the impact of urban lung cancer screening on diverse populations. The importance of routine G6PD screening in oncology patients: A prospective comparative study in African ...

CNN — (CNN) — President Joe Biden’s diagnosis of metastatic prostate cancer has understandably raised concerns and questions: How long has he had cancer, how will he be treated, and what is his ...

Prostate cancer affects one in five Australian men, making it the most common cancer in the country. Now, researchers at the ...